Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterisation of LGP2 complex multitranscript system in humans: role in the innate immune response and evolution from non-human primates.
Martinez-Laso J, Cervera I, Martinez-Carrasco MS, Briz V, Crespo-Bermejo C, Sánchez-Menéndez C, Casado-Fernández G, Torres M, Coiras M. Martinez-Laso J, et al. Among authors: sanchez menendez c. Hum Mol Genet. 2024 Nov 6:ddae155. doi: 10.1093/hmg/ddae155. Online ahead of print. Hum Mol Genet. 2024. PMID: 39505366
Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib.
Manzanares M, Ramos-Martín F, Rodríguez-Mora S, Casado-Fernández G, Sánchez-Menéndez C, Simón-Rueda A, Mateos E, Cervero M, Spivak AM, Planelles V, Torres M, García-Gutiérrez V, Coiras M. Manzanares M, et al. Among authors: sanchez menendez c. Front Pharmacol. 2024 Sep 23;15:1426974. doi: 10.3389/fphar.2024.1426974. eCollection 2024. Front Pharmacol. 2024. PMID: 39380908 Free PMC article.
Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV.
Rodríguez-Mora S, Sánchez-Menéndez C, Bautista-Carrascosa G, Mateos E, Moreno-Serna L, Megías D, Cantón J, García-Gutiérrez V, Murciano-Antón MA, Cervero M, Spivak A, Planelles V, Coiras M. Rodríguez-Mora S, et al. Among authors: sanchez menendez c. Biochem Pharmacol. 2024 Nov;229:116512. doi: 10.1016/j.bcp.2024.116512. Epub 2024 Sep 1. Biochem Pharmacol. 2024. PMID: 39222713 Free article.
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
Casado-Fernández G, Cantón J, Nasarre L, Ramos-Martín F, Manzanares M, Sánchez-Menéndez C, Fuertes D, Mateos E, Murciano-Antón MA, Pérez-Olmeda M, Cervero M, Torres M, Rodríguez-Rosado R, Coiras M. Casado-Fernández G, et al. Among authors: sanchez menendez c. Front Immunol. 2024 May 15;15:1362621. doi: 10.3389/fimmu.2024.1362621. eCollection 2024. Front Immunol. 2024. PMID: 38812512 Free PMC article.
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.
Rodríguez-Mora S, Corona M, Solera Sainero M, Mateos E, Torres M, Sánchez-Menéndez C, Casado-Fernández G, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, Coiras M, García-Gutiérrez V. Rodríguez-Mora S, et al. Among authors: sanchez menendez c. Cancers (Basel). 2023 Oct 20;15(20):5066. doi: 10.3390/cancers15205066. Cancers (Basel). 2023. PMID: 37894433 Free PMC article.
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.
Rodríguez-Mora S, Pérez-Lamas L, Sainero MS, Torres M, Sánchez-Menéndez C, Corona M, Mateos E, Casado-Fernández G, Alcamí J, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, García-Gutiérrez V, Coiras M. Rodríguez-Mora S, et al. Among authors: sanchez menendez c. Cancers (Basel). 2023 Apr 18;15(8):2344. doi: 10.3390/cancers15082344. Cancers (Basel). 2023. PMID: 37190272 Free PMC article.
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster.
Torres M, Corona M, Rodríguez-Mora S, Casado-Fernández G, Zurdo-Castronuño A, Mateos E, Ramos-Martín F, Sánchez-Menéndez C, Murciano-Antón MA, García-Pérez J, Alcamí J, Pérez-Olmeda M, Coiras M, López-Jiménez J, García-Gutiérrez V, On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid. Torres M, et al. Among authors: sanchez menendez c. Cancers (Basel). 2022 Nov 10;14(22):5537. doi: 10.3390/cancers14225537. Cancers (Basel). 2022. PMID: 36428631 Free PMC article.